Table 3.
Significantly enriched GO terms related to cardiovascular system and response to hypoxia for adaptive introgressed genes in the TZG population
| Term ID | Term description | P value | Genes |
|---|---|---|---|
| GO:0060982 | Coronary artery morphogenesis | < 0.001 | Nrp1 (neuropilin 1), Arid2 (AT-rich interaction domain 2) |
| GO:0010613 | Positive regulation of cardiac muscle hypertrophy | < 0.001 | Ankrd55 (ankyrin repeat domain 55), Ece1 (endothelin-converting enzyme 1) |
| GO:0048008 | Platelet-derived growth factor receptor signaling pathway | 0.01 | Fer (FER tyrosine kinase), Nrp1 |
| GO:0008217 | Regulation of blood pressure | 0.02 | Corin (corin, serine peptidase), Ece1 |
| GO:1,904,753 | Negative regulation of vascular associated smooth muscle cell migration | 0.03 | Prkg1 (protein kinase cGMP-dependent 1) |
| GO:0005021 | Vascular endothelial growth factor-activated receptor activity | 0.03 | Nrp1 |
| GO:0035912 | Dorsal aorta morphogenesis | 0.03 | Rbpj (recombination signal binding protein for immunoglobulin kappa J region) |
| GO:0097746 | Regulation of blood vessel diameter | 0.03 | Ece1 |
| GO:0060087 | Relaxation of vascular smooth muscle | 0.04 | Prkg1 |
| GO:0045822 | Negative regulation of heart contraction | 0.04 | Prkg1 |
| GO:0003198 | Epithelial to mesenchymal transition involved in endocardial cushion formation | 0.05 | Rbpj |
| GO:0003214 | Cardiac left ventricle morphogenesis | 0.05 | Rbpj |
| GO:0001666 | Response to hypoxia | 0.05 | Nox4 (NADPH oxidase 4), Ece1, Pam (peptidylglycine alpha-amidating monooxygenase) |
P ≤ 0.05 was considered statistically significant